APO Research
Talk to an analyst

APO RESEARCH · REPORT

Oral Vaccines

Oral vaccines are safe and easy to administer and convenient for all ages. They have been successfully developed to protect from many infectious diseases acquired through oral transmission. Oral delivery of vaccines represents the most attractive mode of administration over other routes of delivery due to the fact that the oral vaccination is noninvasive, safe and simple to execute, showing good patient compliance and clinical practicality.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Oral vaccines are safe and easy to administer and convenient for all ages. They have been successfully developed to protect from many infectious diseases acquired through oral transmission. Oral delivery of vaccines represents the most attractive mode of administration over other routes of delivery due to the fact that the oral vaccination is noninvasive, safe and simple to execute, showing good patient compliance and clinical practicality.

Selected research

Market Structure

Global Oral Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

2 January 2026191 pages

Choose your research edition.

Industry ResearchOral Vaccines Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Oral Vaccines Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Oral Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oral Vaccines Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Oral Vaccines Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

Oral vaccines are safe and easy to administer and convenient for all ages. They have been successfully developed to protect from many infectious diseases acquired through oral transmission. Oral delivery of vaccines represents the most attractive mode of administration over other routes of delivery due to the fact that the oral vaccination is noninvasive, safe and simple to execute, showing good patient compliance and clinical practicality.

The classification of oral vaccines includes rotavirus vaccine, cholera vaccine, oral polio vaccine and other types, and the sales proportion of polio vaccine is about 94%.

Middle East and Africa is the largest consumption place, with a consumption market share nearly 54%. Following Middle East and Africa, Asia-Pacific is the second largest consumption place with the consumption market share of 31%.

Read the full market overview

Market competition is intense. Merck, GSK and Sanofi, etc. are the leaders of the industry, with about 78% market shares.

This report provides an overview of the global Oral Vaccines market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Oral Vaccines and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Oral Vaccines sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Oral Vaccines market size, projected growth trends, production technologies, key applications, and end-use industries.

Oral Vaccines Segment by Company

Merck

GSK

Sanofi

Lanzhou Institute

Serum Institute

Valneva

Shanghai United Cell

Bibcol

PaxVax

Vabiotech

Tiantan Biological

EuBiologics

Panacea Biotec Ltd

Bio-Med

Halfkin Bio-Pharmaceuticals

Oral Vaccines Segment by Type

Rotavirus Vaccine

Cholera Vaccine

Oral Polio Vaccine

Oral Vaccines Segment by Application

Public

Private

Oral Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oral Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Oral Vaccines market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Oral Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Oral Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Oral Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Oral Vaccines Industry Trends Table 2. Oral Vaccines Industry Drivers Table 3. Oral Vaccines Industry Opportunities and Challenges Table 4. Oral Vaccines Industry Restraints Table 5. Global Oral Vaccines Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Oral Vaccines Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Oral Vaccines Sales by Manufacturers (M Doses) & (2021-2026) Table 8. Global Oral Vaccines Sales Market Share by Manufacturers Table 9. Global Oral Vaccines Average Sales Price (USD/K Doses) of Manufacturers (2021-2026) Table 10. Global Oral Vaccines Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Oral Vaccines Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Oral Vaccines Manufacturers, Product Type & Application Table 13. Global Oral Vaccines Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Oral Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Rotavirus Vaccine Table 17. Major Manufacturers of Cholera Vaccine Table 18. Major Manufacturers of Oral Polio Vaccine Table 19. Global Oral Vaccines Sales by Type 2021 VS 2025 VS 2032 (M Doses) Table 20. Global Oral Vaccines Sales by Type (2021-2026) & (M Doses) Table 21. Global Oral Vaccines Sales by Type (2027-2032) & (M Doses) Table 22. Global Oral Vaccines Sales Market Share by Type (2021-2026) Table 23. Global Oral Vaccines Sales Market Share by Type (2027-2032) Table 24. Global Oral Vaccines Revenue by Type 2021 VS 2025 VS 2032 (M Doses) Table 25. Global Oral Vaccines Revenue by Type (2021-2026) & (M Doses) Table 26. Global Oral Vaccines Revenue by Type (2027-2032) & (M Doses) Table 27. Global Oral Vaccines Revenue Market Share by Type (2021-2026) Table 28. Global Oral Vaccines Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Public Table 30. Major Manufacturers of Private Table 31. Global Oral Vaccines Sales by Application 2021 VS 2025 VS 2032 (M Doses) Table 32. Global Oral Vaccines Sales by Application (2021-2026) & (M Doses) Table 33. Global Oral Vaccines Sales by Application (2027-2032) & (M Doses) Table 34. Global Oral Vaccines Sales Market Share by Application (2021-2026) Table 35. Global Oral Vaccines Sales Market Share by Application (2027-2032) Table 36. Global Oral Vaccines Revenue by Application 2021 VS 2025 VS 2032 (M Doses) Table 37. Global Oral Vaccines Revenue by Application (2021-2026) & (M Doses) Table 38. Global Oral Vaccines Revenue by Application (2027-2032) & (M Doses) Table 39. Global Oral Vaccines Revenue Market Share by Application (2021-2026) Table 40. Global Oral Vaccines Revenue Market Share by Application (2027-2032) Table 41. Global Oral Vaccines Sales by Region: 2021 VS 2025 VS 2032 (M Doses) Table 42. Global Oral Vaccines Sales by Region (2021-2026) & (M Doses) Table 43. Global Oral Vaccines Sales Market Share by Region (2021-2026) Table 44. Global Oral Vaccines Sales Forecasted by Region (2027-2032) & (M Doses) Table 45. Global Oral Vaccines Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Oral Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Doses) Table 47. North America Oral Vaccines Sales by Country (2021-2026) & (M Doses) Table 48. North America Oral Vaccines Sales by Country (2027-2032) & (M Doses) Table 49. Europe Oral Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Doses) Table 50. Europe Oral Vaccines Sales by Country (2021-2026) & (M Doses) Table 51. Europe Oral Vaccines Sales by Country (2027-2032) & (M Doses) Table 52. Asia Pacific Oral Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Doses) Table 53. Asia Pacific Oral Vaccines Sales by Country (2021-2026) & (M Doses) Table 54. Asia Pacific Oral Vaccines Sales by Country (2027-2032) & (M Doses) Table 55. South America, Middle East and Africa Oral Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Doses) Table 56. South America, Middle East and Africa Oral Vaccines Sales by Country (2021-2026) & (M Doses) Table 57. South America, Middle East and Africa Oral Vaccines Sales by Country (2027-2032) & (M Doses) Table 58. Global Oral Vaccines Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Oral Vaccines Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Oral Vaccines Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Oral Vaccines Revenue Market Share by Region (2021-2026) Table 62. Global Oral Vaccines Revenue Market Share by Region (2027-2032) Table 63. Merck Company Information Table 64. Merck Business Overview Table 65. Merck Oral Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Merck Oral Vaccines Product Portfolio Table 67. Merck Recent Development Table 68. GSK Company Information Table 69. GSK Business Overview Table 70. GSK Oral Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. GSK Oral Vaccines Product Portfolio Table 72. GSK Recent Development Table 73. Sanofi Company Information Table 74. Sanofi Business Overview Table 75. Sanofi Oral Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Sanofi Oral Vaccines Product Portfolio Table 77. Sanofi Recent Development Table 78. Lanzhou Institute Company Information Table 79. Lanzhou Institute Business Overview Table 80. Lanzhou Institute Oral Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Lanzhou Institute Oral Vaccines Product Portfolio Table 82. Lanzhou Institute Recent Development Table 83. Serum Institute Company Information Table 84. Serum Institute Business Overview Table 85. Serum Institute Oral Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Serum Institute Oral Vaccines Product Portfolio Table 87. Serum Institute Recent Development Table 88. Valneva Company Information Table 89. Valneva Business Overview Table 90. Valneva Oral Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Valneva Oral Vaccines Product Portfolio Table 92. Valneva Recent Development Table 93. Shanghai United Cell Company Information Table 94. Shanghai United Cell Business Overview Table 95. Shanghai United Cell Oral Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Shanghai United Cell Oral Vaccines Product Portfolio Table 97. Shanghai United Cell Recent Development Table 98. Bibcol Company Information Table 99. Bibcol Business Overview Table 100. Bibcol Oral Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Bibcol Oral Vaccines Product Portfolio Table 102. Bibcol Recent Development Table 103. PaxVax Company Information Table 104. PaxVax Business Overview Table 105. PaxVax Oral Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. PaxVax Oral Vaccines Product Portfolio Table 107. PaxVax Recent Development Table 108. Vabiotech Company Information Table 109. Vabiotech Business Overview Table 110. Vabiotech Oral Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Vabiotech Oral Vaccines Product Portfolio Table 112. Vabiotech Recent Development Table 113. Tiantan Biological Company Information Table 114. Tiantan Biological Business Overview Table 115. Tiantan Biological Oral Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Tiantan Biological Oral Vaccines Product Portfolio Table 117. Tiantan Biological Recent Development Table 118. EuBiologics Company Information Table 119. EuBiologics Business Overview Table 120. EuBiologics Oral Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. EuBiologics Oral Vaccines Product Portfolio Table 122. EuBiologics Recent Development Table 123. Panacea Biotec Ltd Company Information Table 124. Panacea Biotec Ltd Business Overview Table 125. Panacea Biotec Ltd Oral Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Panacea Biotec Ltd Oral Vaccines Product Portfolio Table 127. Panacea Biotec Ltd Recent Development Table 128. Bio-Med Company Information Table 129. Bio-Med Business Overview Table 130. Bio-Med Oral Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Bio-Med Oral Vaccines Product Portfolio Table 132. Bio-Med Recent Development Table 133. Halfkin Bio-Pharmaceuticals Company Information Table 134. Halfkin Bio-Pharmaceuticals Business Overview Table 135. Halfkin Bio-Pharmaceuticals Oral Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. Halfkin Bio-Pharmaceuticals Oral Vaccines Product Portfolio Table 137. Halfkin Bio-Pharmaceuticals Recent Development Table 138. Key Raw Materials Table 139. Raw Materials Key Suppliers Table 140. Oral Vaccines Distributors List Table 141. Oral Vaccines Customers List Table 142. Research Programs/Design for This Report Table 143. Authors List of This Report Table 144. Secondary Sources Table 145. Primary Sources List of Figures Figure 1. Oral Vaccines Product Image Figure 2. Global Oral Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Oral Vaccines Market Size (2021-2032) & (US$ Million) Figure 4. Global Oral Vaccines Sales (2021-2032) & (M Doses) Figure 5. Global Oral Vaccines Average Price (USD/K Doses) & (2021-2032) Figure 6. Global Top 5 and 10 Oral Vaccines Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Rotavirus Vaccine Image Figure 9. Cholera Vaccine Image Figure 10. Oral Polio Vaccine Image Figure 11. Global Oral Vaccines Sales by Type (2021 VS 2025 VS 2032) & (M Doses) Figure 12. Global Oral Vaccines Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Oral Vaccines Sales Market Share by Type (2021-2032) Figure 14. Global Oral Vaccines Revenue by Type (2021 VS 2025 VS 2032) & (M Doses) Figure 15. Global Oral Vaccines Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Oral Vaccines Revenue Market Share by Type (2021-2032) Figure 17. Public Image Figure 18. Private Image Figure 19. Global Oral Vaccines Sales by Application (2021 VS 2025 VS 2032) & (M Doses) Figure 20. Global Oral Vaccines Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Oral Vaccines Sales Market Share by Application (2021-2032) Figure 22. Global Oral Vaccines Revenue by Application (2021 VS 2025 VS 2032) & (M Doses) Figure 23. Global Oral Vaccines Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Oral Vaccines Revenue Market Share by Application (2021-2032) Figure 25. North America Oral Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 26. North America Oral Vaccines Sales Market Share by Country (2021-2032) Figure 27. U.S. Oral Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 28. Canada Oral Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 29. Mexico Oral Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 30. Europe Oral Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 31. Europe Oral Vaccines Sales Market Share by Country (2021-2032) Figure 32. Germany Oral Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 33. France Oral Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 34. U.K. Oral Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 35. Italy Oral Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 36. Netherlands Oral Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 37. Asia Pacific Oral Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 38. Asia Pacific Oral Vaccines Sales Market Share by Country (2021-2032) Figure 39. China Oral Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 40. Japan Oral Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 41. South Korea Oral Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 42. Southeast Asia Oral Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 43. India Oral Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 44. Australia Oral Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 45. South America, Middle East and Africa Oral Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 46. South America, Middle East and Africa Oral Vaccines Sales Market Share by Country (2021-2032) Figure 47. Brazil Oral Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 48. South Africa Oral Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 49. Saudi Arabia Oral Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 50. Turkey Oral Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 51. Argentina Oral Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 52. UAE Oral Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 53. Egypt Oral Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 54. Chile Oral Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 55. Global Oral Vaccines Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Oral Vaccines Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Oral Vaccines Revenue (2021-2032) & (US$ Million) Figure 58. North America Oral Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Oral Vaccines Revenue (2021-2032) & (US$ Million) Figure 60. Europe Oral Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Oral Vaccines Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Oral Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Oral Vaccines Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Oral Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Oral Vaccines Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Oral Vaccines Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Rotavirus Vaccine
  • Cholera Vaccine
  • Oral Polio Vaccine
Applications
  • Public
  • Private
Companies covered
  • Merck
  • GSK
  • Sanofi
  • Lanzhou Institute
  • Serum Institute
  • Valneva
  • Shanghai United Cell
  • Bibcol
  • PaxVax
  • Vabiotech
  • Tiantan Biological
  • EuBiologics
  • Panacea Biotec Ltd
  • Bio-Med
  • Halfkin Bio-Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Oral Vaccines Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Oral Vaccines Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Oral Vaccines Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Oral Vaccines Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Oral Vaccines Market Dynamics
  1. 2.1 Oral Vaccines Industry Trends
  2. 2.2 Oral Vaccines Industry Drivers
  3. 2.3 Oral Vaccines Industry Opportunities and Challenges
  4. 2.4 Oral Vaccines Industry Restraints
3 Oral Vaccines Market by Manufacturers
  1. 3.1 Global Oral Vaccines Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Oral Vaccines Sales by Manufacturers (2021-2026)
  3. 3.3 Global Oral Vaccines Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Oral Vaccines Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Oral Vaccines Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Oral Vaccines Manufacturers, Product Type & Application
  7. 3.7 Global Oral Vaccines Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Oral Vaccines Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Oral Vaccines Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Oral Vaccines Tier 1, Tier 2, and Tier 3
4 Oral Vaccines Market by Type
  1. 4.1 Oral Vaccines Type Introduction
  2. 4.1.1 Rotavirus Vaccine
  3. 4.1.2 Cholera Vaccine
  4. 4.1.3 Oral Polio Vaccine
  5. 4.2 Global Oral Vaccines Sales by Type
  6. 4.2.1 Global Oral Vaccines Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Oral Vaccines Sales by Type (2021-2032)
  8. 4.2.3 Global Oral Vaccines Sales Market Share by Type (2021-2032)
  9. 4.3 Global Oral Vaccines Revenue by Type
  10. 4.3.1 Global Oral Vaccines Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Oral Vaccines Revenue by Type (2021-2032)
  12. 4.3.3 Global Oral Vaccines Revenue Market Share by Type (2021-2032)
5 Oral Vaccines Market by Application
  1. 5.1 Oral Vaccines Application Introduction
  2. 5.1.1 Public
  3. 5.1.2 Private
  4. 5.2 Global Oral Vaccines Sales by Application
  5. 5.2.1 Global Oral Vaccines Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Oral Vaccines Sales by Application (2021-2032)
  7. 5.2.3 Global Oral Vaccines Sales Market Share by Application (2021-2032)
  8. 5.3 Global Oral Vaccines Revenue by Application
  9. 5.3.1 Global Oral Vaccines Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Oral Vaccines Revenue by Application (2021-2032)
  11. 5.3.3 Global Oral Vaccines Revenue Market Share by Application (2021-2032)
6 Global Oral Vaccines Sales by Region
  1. 6.1 Global Oral Vaccines Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Oral Vaccines Sales by Region (2021-2032)
  3. 6.2.1 Global Oral Vaccines Sales by Region (2021-2026)
  4. 6.2.2 Global Oral Vaccines Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Oral Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Oral Vaccines Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Oral Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Oral Vaccines Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Oral Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Oral Vaccines Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Oral Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Oral Vaccines Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Oral Vaccines Revenue by Region
  1. 7.1 Global Oral Vaccines Revenue by Region
  2. 7.1.1 Global Oral Vaccines Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Oral Vaccines Revenue by Region (2021-2026)
  4. 7.1.3 Global Oral Vaccines Revenue by Region (2027-2032)
  5. 7.1.4 Global Oral Vaccines Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Oral Vaccines Revenue (2021-2032)
  8. 7.2.2 North America Oral Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Oral Vaccines Revenue (2021-2032)
  11. 7.3.2 Europe Oral Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Oral Vaccines Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Oral Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Oral Vaccines Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Oral Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Merck
  2. 8.1.1 Merck Company Information
  3. 8.1.2 Merck Business Overview
  4. 8.1.3 Merck Oral Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Merck Oral Vaccines Product Portfolio
  6. 8.1.5 Merck Recent Developments
  7. 8.2 GSK
  8. 8.2.1 GSK Company Information
  9. 8.2.2 GSK Business Overview
  10. 8.2.3 GSK Oral Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 GSK Oral Vaccines Product Portfolio
  12. 8.2.5 GSK Recent Developments
  13. 8.3 Sanofi
  14. 8.3.1 Sanofi Company Information
  15. 8.3.2 Sanofi Business Overview
  16. 8.3.3 Sanofi Oral Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Sanofi Oral Vaccines Product Portfolio
  18. 8.3.5 Sanofi Recent Developments
  19. 8.4 Lanzhou Institute
  20. 8.4.1 Lanzhou Institute Company Information
  21. 8.4.2 Lanzhou Institute Business Overview
  22. 8.4.3 Lanzhou Institute Oral Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Lanzhou Institute Oral Vaccines Product Portfolio
  24. 8.4.5 Lanzhou Institute Recent Developments
  25. 8.5 Serum Institute
  26. 8.5.1 Serum Institute Company Information
  27. 8.5.2 Serum Institute Business Overview
  28. 8.5.3 Serum Institute Oral Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Serum Institute Oral Vaccines Product Portfolio
  30. 8.5.5 Serum Institute Recent Developments
  31. 8.6 Valneva
  32. 8.6.1 Valneva Company Information
  33. 8.6.2 Valneva Business Overview
  34. 8.6.3 Valneva Oral Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Valneva Oral Vaccines Product Portfolio
  36. 8.6.5 Valneva Recent Developments
  37. 8.7 Shanghai United Cell
  38. 8.7.1 Shanghai United Cell Company Information
  39. 8.7.2 Shanghai United Cell Business Overview
  40. 8.7.3 Shanghai United Cell Oral Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Shanghai United Cell Oral Vaccines Product Portfolio
  42. 8.7.5 Shanghai United Cell Recent Developments
  43. 8.8 Bibcol
  44. 8.8.1 Bibcol Company Information
  45. 8.8.2 Bibcol Business Overview
  46. 8.8.3 Bibcol Oral Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Bibcol Oral Vaccines Product Portfolio
  48. 8.8.5 Bibcol Recent Developments
  49. 8.9 PaxVax
  50. 8.9.1 PaxVax Company Information
  51. 8.9.2 PaxVax Business Overview
  52. 8.9.3 PaxVax Oral Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 PaxVax Oral Vaccines Product Portfolio
  54. 8.9.5 PaxVax Recent Developments
  55. 8.10 Vabiotech
  56. 8.10.1 Vabiotech Company Information
  57. 8.10.2 Vabiotech Business Overview
  58. 8.10.3 Vabiotech Oral Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Vabiotech Oral Vaccines Product Portfolio
  60. 8.10.5 Vabiotech Recent Developments
  61. 8.11 Tiantan Biological
  62. 8.11.1 Tiantan Biological Company Information
  63. 8.11.2 Tiantan Biological Business Overview
  64. 8.11.3 Tiantan Biological Oral Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Tiantan Biological Oral Vaccines Product Portfolio
  66. 8.11.5 Tiantan Biological Recent Developments
  67. 8.12 EuBiologics
  68. 8.12.1 EuBiologics Company Information
  69. 8.12.2 EuBiologics Business Overview
  70. 8.12.3 EuBiologics Oral Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 EuBiologics Oral Vaccines Product Portfolio
  72. 8.12.5 EuBiologics Recent Developments
  73. 8.13 Panacea Biotec Ltd
  74. 8.13.1 Panacea Biotec Ltd Company Information
  75. 8.13.2 Panacea Biotec Ltd Business Overview
  76. 8.13.3 Panacea Biotec Ltd Oral Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Panacea Biotec Ltd Oral Vaccines Product Portfolio
  78. 8.13.5 Panacea Biotec Ltd Recent Developments
  79. 8.14 Bio-Med
  80. 8.14.1 Bio-Med Company Information
  81. 8.14.2 Bio-Med Business Overview
  82. 8.14.3 Bio-Med Oral Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Bio-Med Oral Vaccines Product Portfolio
  84. 8.14.5 Bio-Med Recent Developments
  85. 8.15 Halfkin Bio-Pharmaceuticals
  86. 8.15.1 Halfkin Bio-Pharmaceuticals Company Information
  87. 8.15.2 Halfkin Bio-Pharmaceuticals Business Overview
  88. 8.15.3 Halfkin Bio-Pharmaceuticals Oral Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Halfkin Bio-Pharmaceuticals Oral Vaccines Product Portfolio
  90. 8.15.5 Halfkin Bio-Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Oral Vaccines Value Chain Analysis
  2. 9.1.1 Oral Vaccines Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Oral Vaccines Production Mode & Process
  6. 9.2 Oral Vaccines Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Oral Vaccines Distributors
  9. 9.2.3 Oral Vaccines Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst